{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:52:33Z","timestamp":1778835153037,"version":"3.51.4"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Scientific Technology and Development Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed at exploring the potential role of a panel of serum micro-RNA (miRNA) markers in liver fibrosis and hepatocellular carcinoma (HCC) diagnosis in patients with chronic hepatitis C virus (HCV) infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study included 157 chronic HCV patients and 62 HCC patients who presented to the Cairo University Center for Hepatic Fibrosis, Endemic Medicine Department, from 2015 to 2017. Relevant clinical and laboratory data were collected and sera were subjected to miRNA expression profiling. Eleven miRNA markers were studied and receiver operating characteristic curves were constructed to investigate the best cutoff values of the miRNAs that showed altered expression in HCC compared to HCV-associated advanced fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>miRNA expression profiling revealed 5 miRNAs (miR-124, miR-141, miR-205, miR-208a, miR-499a) were significantly upregulated and 2 miRNAs were significantly downregulated (miR-103a, miR-15a) in HCC compared to advanced fibrosis patients. No significant difference was observed in miRNA expression between advanced fibrosis and early hepatic fibrosis apart from a significant downregulation of miR-155-5p in advanced fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Serum miRNAs could serve as potential diagnostic tools for the diagnosis of HCC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmac045","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:08:56Z","timestamp":1649934536000},"page":"523-529","source":"Crossref","is-referenced-by-count":7,"title":["Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC"],"prefix":"10.1093","volume":"53","author":[{"given":"Ayman","family":"Yosry","sequence":"first","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham M","family":"Dawood","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, Genetic Engineering Division, National Research Centre , Dokki, Giza , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa K","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, Genetic Engineering Division, National Research Centre , Dokki, Giza , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Elsharkawy","sequence":"additional","affiliation":[{"name":"Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M","family":"Ekladious","sequence":"additional","affiliation":[{"name":"Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Khairy","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Khairy","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-0130","authenticated-orcid":false,"given":"Shereen","family":"Abdel Alem","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha G","family":"Bader El Din","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, Genetic Engineering Division, National Research Centre , Dokki, Giza , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa K","family":"El Awady","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, Genetic Engineering Division, National Research Centre , Dokki, Giza , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4468-493X","authenticated-orcid":false,"given":"Zeinab","family":"Abdellatif","sequence":"additional","affiliation":[{"name":"Endemic Medicine and Hepatology Department, Faculty of Medicine, Cairo University , Cairo , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"issue":"15","key":"2022090114002335800_CIT0001","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med."},{"issue":"12","key":"2022090114002335800_CIT0002","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"issue":"33","key":"2022090114002335800_CIT0003","first-page":"5193","article-title":"Hepatocellular carcinoma in Egypt: a single center study over a decade","volume":"11","author":"El-Zayadi","year":"2005","journal-title":"World J Gastroenterol."},{"issue":"1","key":"2022090114002335800_CIT0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/sajc.sajc_82_17","article-title":"Epidemiology of liver cancer in Nile delta over a decade: a single-center study","volume":"7","author":"Abd-Elsalam","year":"2018","journal-title":"South Asian J Cancer."},{"issue":"4","key":"2022090114002335800_CIT0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jnci.2016.06.001","article-title":"Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center study","volume":"28","author":"Ziada","year":"2016","journal-title":"J Egypt Natl Canc Inst."},{"issue":"1","key":"2022090114002335800_CIT0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1089-3261(05)70155-0","article-title":"Epidemiology of hepatocellular carcinoma","volume":"5","author":"El Serag","year":"2001","journal-title":"Clin Liver Dis."},{"issue":"4","key":"2022090114002335800_CIT0007","doi-asserted-by":"crossref","first-page":"e1001624","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLoS Med."},{"key":"2022090114002335800_CIT0008","doi-asserted-by":"crossref","first-page":"169\u2013","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","author":"Simmons","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2022090114002335800_CIT0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep.1840190111","article-title":"Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma","volume":"19","author":"Oka","year":"1994","journal-title":"Hepatology."},{"issue":"5","key":"2022090114002335800_CIT0010","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jhep.2003.50195","article-title":"Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients","volume":"37","author":"Marrero","year":"2003","journal-title":"Hepatology."},{"issue":"13","key":"2022090114002335800_CIT0011","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3748\/wjg.v21.i13.3928","article-title":"Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma","volume":"21","author":"Seo","year":"2015","journal-title":"World J Gastroenterol."},{"issue":"8","key":"2022090114002335800_CIT0012","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jjco\/hyv063","article-title":"MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma","volume":"45","author":"Huang","year":"2015","journal-title":"Jpn J Clin Oncol."},{"issue":"4","key":"2022090114002335800_CIT0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2013.10.157","article-title":"MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3","volume":"441","author":"Lu","year":"2013","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"2022090114002335800_CIT0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/jhg.2016.53","article-title":"MicroRNAs and liver disease","volume":"62","author":"Otsuka","year":"2017","journal-title":"J Hum Genet."},{"issue":"1","key":"2022090114002335800_CIT0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13105-010-0050-6","article-title":"Biological functions of microRNAs: a review","volume":"67","author":"Huang","year":"2011","journal-title":"J Physiol Biochem."},{"issue":"2","key":"2022090114002335800_CIT0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/iub.2164","article-title":"MicroRNAs expression profiling in Egyptian colorectal cancer patients","volume":"72","author":"Bader El Din","year":"2020","journal-title":"IUBMB Life."},{"issue":"2","key":"2022090114002335800_CIT0017","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjc.6606010","article-title":"The role of microRNAs in liver cancer progression","volume":"104","author":"Huang","year":"2011","journal-title":"Br J Cancer."},{"issue":"4","key":"2022090114002335800_CIT0018","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy","volume":"54","author":"Tsochatzis","year":"2011","journal-title":"J Hepatol."},{"issue":"3","key":"2022090114002335800_CIT0019","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology."},{"issue":"2","key":"2022090114002335800_CIT0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/SLA.0000000000000223","article-title":"Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus","volume":"259","author":"Yeh","year":"2014","journal-title":"Ann Surg"},{"key":"2022090114002335800_CIT0021","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.2147\/OTT.S288791","article-title":"Mechanisms and functions of MiR-200 family in hepatocellular carcinoma","volume":"13","author":"Mao","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"32","key":"2022090114002335800_CIT0022","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.3748\/wjg.v19.i32.5212","article-title":"MicroRNAs and liver cancer associated with iron overload: therapeutic targets unraveled","volume":"19","author":"Greene","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2022090114002335800_CIT0023","article-title":"Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+ T cells and suppresses the hepatocellular carcinoma progression","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"2022090114002335800_CIT0024","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cas.13177","article-title":"MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K\/Akt pathway","volume":"108","author":"Fu","year":"2017","journal-title":"Cancer Sci."},{"issue":"3","key":"2022090114002335800_CIT0025","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.3892\/ol.2020.11852","article-title":"MicroRNA-574-3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28","volume":"20","author":"Zha","year":"2020","journal-title":"Oncol Lett"},{"issue":"6","key":"2022090114002335800_CIT0026","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-021-03905-3","article-title":"MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"2022090114002335800_CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18050910","article-title":"miR-103 promotes proliferation and metastasis by targeting KLF4 in gastric cancer","volume":"18","author":"Zheng","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2022090114002335800_CIT0028","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yexcr.2015.07.008","article-title":"miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression","volume":"336","author":"Yu","year":"2015","journal-title":"Exp Cell Res"},{"issue":"5","key":"2022090114002335800_CIT0029","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"2022090114002335800_CIT0030","author":"LeDell E, Poirier S"},{"issue":"4","key":"2022090114002335800_CIT0031","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.seminoncol.2012.05.009","article-title":"New serum markers of hepatocellular carcinoma","volume":"39","author":"Masuzaki","year":"2012","journal-title":"Semin Oncol"},{"issue":"3","key":"2022090114002335800_CIT0032","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","article-title":"Advances in the early diagnosis of hepatocellular carcinoma,","volume":"7","author":"Wang","year":"2020","journal-title":"Genes Dis."},{"issue":"30","key":"2022090114002335800_CIT0033","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"2022090114002335800_CIT0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/abbs\/gmq114","article-title":"Stability analysis of liver cancer-related microRNAs","volume":"43","author":"Li","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"issue":"2","key":"2022090114002335800_CIT0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yexcr.2015.07.008","article-title":"miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression","volume":"336","author":"Yu","year":"2015","journal-title":"Exp Cell Res."},{"issue":"4","key":"2022090114002335800_CIT0036","first-page":"5517","article-title":"MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: a quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study","volume":"15","author":"He","year":"2018","journal-title":"Oncol Lett."},{"issue":"2","key":"2022090114002335800_CIT0037","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/gut.2011.239145","article-title":"The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2","volume":"61","author":"Zheng","year":"2012","journal-title":"Gut"},{"key":"2022090114002335800_CIT0038","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijbiomac.2019.01.144","article-title":"Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell","volume":"128","author":"Hou","year":"2019","journal-title":"Int J Biol Macromol."},{"issue":"2","key":"2022090114002335800_CIT0039","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejcb.2012.11.002","article-title":"MiR-205 in cancer: an angel or a devil?","volume":"92","author":"Qin","year":"2013","journal-title":"Eur J Cell Biol."},{"issue":"1","key":"2022090114002335800_CIT0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yexmp.2015.12.010","article-title":"MiR-205 functions as a tumor suppressor via targeting TGF-alpha in osteosarcoma","volume":"100","author":"Yang","year":"2016","journal-title":"Exp Mol Pathol."},{"issue":"24","key":"2022090114002335800_CIT0041","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/cncr.25488","article-title":"MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer","volume":"116","author":"Majid","year":"2010","journal-title":"Cancer"},{"issue":"11","key":"2022090114002335800_CIT0042","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1159\/000368792","article-title":"miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma","volume":"37","author":"Chen","year":"2014","journal-title":"Oncol Res Treat"},{"issue":"11","key":"2022090114002335800_CIT0043","first-page":"12375","article-title":"Association of serum miR-205 with liver cirrhosis and cancer and its diagnostic significance","volume":"11","author":"Zhu","year":"2018","journal-title":"Int J Clin Exp Med."},{"issue":"6","key":"2022090114002335800_CIT0044","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1007\/s11033-012-1532-0","article-title":"Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population","volume":"39","author":"Xiang","year":"2012","journal-title":"Mol Biol Rep."},{"issue":"2","key":"2022090114002335800_CIT0045","doi-asserted-by":"crossref","first-page":"e0211581","DOI":"10.1371\/journal.pone.0211581","article-title":"The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma","volume":"14","author":"Bai","year":"2019","journal-title":"PLoS One"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/5\/523\/45640254\/lmac045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/5\/523\/45640254\/lmac045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T15:01:21Z","timestamp":1662044481000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/53\/5\/523\/6613252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,6,22]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmac045","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,6,22]]}}}